|
1
|
Induction of B7-1 in podocytes is associated with nephrotic syndrome.
|
J Clin Invest
|
2004
|
4.65
|
|
2
|
Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.
|
Cancer Res
|
2003
|
2.62
|
|
3
|
Similarities and differences between selective and nonselective BAFF blockade in murine SLE.
|
J Clin Invest
|
2006
|
2.05
|
|
4
|
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.
|
J Immunol
|
2008
|
1.79
|
|
5
|
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.
|
J Immunol
|
2003
|
1.74
|
|
6
|
Taming lupus-a new understanding of pathogenesis is leading to clinical advances.
|
Nat Med
|
2012
|
1.63
|
|
7
|
Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.
|
Arthritis Rheum
|
2010
|
1.55
|
|
8
|
Structure and function of renal macrophages and dendritic cells from lupus-prone mice.
|
Arthritis Rheumatol
|
2014
|
1.54
|
|
9
|
Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus.
|
J Immunol
|
2004
|
1.53
|
|
10
|
Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma.
|
Carcinogenesis
|
2007
|
1.51
|
|
11
|
BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.
|
Eur J Immunol
|
2004
|
1.44
|
|
12
|
Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
|
Arthritis Rheum
|
2005
|
1.41
|
|
13
|
Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice.
|
Arthritis Rheum
|
2010
|
1.37
|
|
14
|
BAFF and selection of autoreactive B cells.
|
Trends Immunol
|
2011
|
1.36
|
|
15
|
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages.
|
Proc Natl Acad Sci U S A
|
2010
|
1.33
|
|
16
|
Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
|
Arthritis Rheum
|
2011
|
1.29
|
|
17
|
A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.
|
J Immunol
|
2011
|
1.25
|
|
18
|
Prevention of murine antiphospholipid syndrome by BAFF blockade.
|
Arthritis Rheum
|
2008
|
1.22
|
|
19
|
Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.
|
J Immunol
|
2012
|
1.21
|
|
20
|
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.
|
Arthritis Rheum
|
2012
|
1.18
|
|
21
|
The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.
|
Arthritis Rheum
|
2002
|
1.12
|
|
22
|
Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus.
|
J Immunol
|
2002
|
1.11
|
|
23
|
Targeting of the immune system in systemic lupus erythematosus.
|
Expert Rev Mol Med
|
2008
|
1.08
|
|
24
|
Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
|
J Immunol
|
2005
|
1.08
|
|
25
|
BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus.
|
J Immunol
|
2011
|
1.06
|
|
26
|
Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B.
|
J Immunol
|
2006
|
1.06
|
|
27
|
Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.
|
Arthritis Rheum
|
2009
|
1.05
|
|
28
|
BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?
|
Immunol Rev
|
2008
|
1.03
|
|
29
|
Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
|
Arthritis Rheum
|
2003
|
1.00
|
|
30
|
IFNα Inducible Models of Murine SLE.
|
Front Immunol
|
2013
|
0.97
|
|
31
|
Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice.
|
PLoS One
|
2010
|
0.94
|
|
32
|
The Yaa locus and IFN-α fine-tune germinal center B cell selection in murine systemic lupus erythematosus.
|
J Immunol
|
2012
|
0.94
|
|
33
|
IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.
|
J Immunol
|
2011
|
0.93
|
|
34
|
CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice.
|
Autoimmunity
|
2004
|
0.92
|
|
35
|
Plasma cells in systemic lupus erythematosus: the long and short of it all.
|
Eur J Immunol
|
2011
|
0.92
|
|
36
|
B-cell activating factor targeted therapy and lupus.
|
Arthritis Res Ther
|
2012
|
0.92
|
|
37
|
BAFF inhibition: a new class of drugs for the treatment of autoimmunity.
|
Exp Cell Res
|
2011
|
0.91
|
|
38
|
Representation of ecological systems within the protected areas network of the Continental United States.
|
PLoS One
|
2013
|
0.90
|
|
39
|
Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.
|
PLoS One
|
2013
|
0.87
|
|
40
|
The current status of targeting BAFF/BLyS for autoimmune diseases.
|
Arthritis Res Ther
|
2004
|
0.87
|
|
41
|
Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.
|
Arthritis Rheum
|
2012
|
0.86
|
|
42
|
Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling.
|
J Immunol
|
2007
|
0.83
|
|
43
|
Analysis of renal mononuclear phagocytes in murine models of SLE.
|
Methods Mol Biol
|
2012
|
0.80
|
|
44
|
Activated basophils give lupus a booster shot.
|
Nat Med
|
2010
|
0.78
|
|
45
|
Systemic lupus erythematosus.
|
Clin Dev Immunol
|
2012
|
0.78
|
|
46
|
From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.
|
J Data Mining Genomics Proteomics
|
2012
|
0.78
|
|
47
|
Discitis in toddlers: a case series and review.
|
Acta Paediatr
|
2005
|
0.76
|
|
48
|
Inhibitory short synthetic oligodeoxynucleotides and lupus.
|
Arthritis Res Ther
|
2009
|
0.76
|
|
49
|
The multiple chemokine-binding bovine herpesvirus 1 glycoprotein G (BHV1gG) inhibits polymorphonuclear cell but not monocyte migration into inflammatory sites.
|
Mol Med
|
2013
|
0.75
|
|
50
|
Tinea versicolor associated with etanercept therapy.
|
J Am Acad Dermatol
|
2008
|
0.75
|
|
51
|
Patient identification in blood sampling.
|
Nurs Times
|
2014
|
0.75
|
|
52
|
Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection.
|
J Rheumatol
|
2005
|
0.75
|
|
53
|
Standard UK autologous transfusion label.
|
J Perioper Pract
|
2015
|
0.75
|